Avinoam Kadouri
Corporate Officer/Principal chez Weizmann Institute of Science
Postes actifs de Avinoam Kadouri
Sociétés | Poste | Début | Fin |
---|---|---|---|
Weizmann Institute of Science | Corporate Officer/Principal | - | - |
Historique de carrière de Avinoam Kadouri
Anciens postes connus de Avinoam Kadouri
Sociétés | Poste | Début | Fin |
---|---|---|---|
BONUS BIOGROUP LTD. | Directeur Technique/Scientifique/R&D | 04/10/1981 | 01/09/2016 |
Fondateur | 04/10/1981 | 01/09/2016 | |
The European Association for Bioindustries | Président | - | - |
Animal Cell Technology Industrial Platform | Président | - | - |
Serono International SA | Corporate Officer/Principal | - | - |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Directeur Technique/Scientifique/R&D | 28/07/2009 | - |
Corporate Officer/Principal | - | 28/07/2009 | |
Uni Targeting Research AS
Uni Targeting Research AS BiotechnologyHealth Technology Uni Targeting Research AS is a holding company that provides the biopharmaceutical industry with tools and services for mammalian cell-line based development procedures and production processes. It offers upstream solutions to reduce complementary deoxyribonucleic acid and mammalian cell-line based timelines and increase protein production yields. Its technology enables both enhanced synthesis/secretion of naturally secreted proteins, and secretion of intracellular proteins. Its services include vector improvement, tailor-made vectors, and tool proteins. The company was founded by Ian Fraser Pryme, John E. Hesketh, Albert Tauler, and Beate Stern in 2001 and is headquartered in Bergen, Norway. | Directeur Technique/Scientifique/R&D | - | - |
Statistiques
Internationale
Israël | 3 |
Etats-Unis | 3 |
Norvège | 2 |
Opérationnelle
Chief Tech/Sci/R&D Officer | 3 |
Corporate Officer/Principal | 3 |
Chairman | 2 |
Sectorielle
Health Technology | 4 |
Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
BONUS BIOGROUP LTD. | Health Technology |
Entreprise privées | 5 |
---|---|
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Health Technology |
Uni Targeting Research AS
Uni Targeting Research AS BiotechnologyHealth Technology Uni Targeting Research AS is a holding company that provides the biopharmaceutical industry with tools and services for mammalian cell-line based development procedures and production processes. It offers upstream solutions to reduce complementary deoxyribonucleic acid and mammalian cell-line based timelines and increase protein production yields. Its technology enables both enhanced synthesis/secretion of naturally secreted proteins, and secretion of intracellular proteins. Its services include vector improvement, tailor-made vectors, and tool proteins. The company was founded by Ian Fraser Pryme, John E. Hesketh, Albert Tauler, and Beate Stern in 2001 and is headquartered in Bergen, Norway. | Health Technology |
The European Association for Bioindustries | |
Serono International SA | |
Animal Cell Technology Industrial Platform |
- Bourse
- Insiders
- Avinoam Kadouri
- Expérience